This is a past event. Registration is closed. View other Corporate Council on Africa events.
Corporate Council on Africa's
Health Working Group
Presents
First Malaria Vaccine in Africa:
Partnership Opportunities to Expand Vaccine Access
With guest speakers:
Ashley Birkett
Director, PATH's Malaria Vaccine Initiative
Dr. Mary Hamel
Lead, Malaria Vaccine Implementation Programme, WHO
Dr. Kwaku Poku (KP) Asante
Director, Kintampo Health Research Centre
Speaker (TBC)
GSK Vaccines
Tuesday, November 19, 2019
3:00 pm – 4:30 pm
Corporate Council on Africa
1100 17th St N.W., Suite 1200
Washington, DC 20036
Each year, malaria claims the lives of more than 400,000 people, with one child dying from malaria every two minutes. Today, the world's first malaria vaccine is reaching thousands of children in Africa through a vaccine pilot program in selected areas of Ghana, Kenya and Malawi. This is the first and only vaccine that has demonstrated it can significantly reduce malaria and life-threatening severe malaria in young African children.
Join CCA for a roundtable discussion including representatives from GSK, PATH, and WHO. Speakers will share the latest updates on the Malaria Vaccine Implementation Programme (MVIP) and the partnership opportunities for private sector companies interested in supporting the implementation program and expanding access to the vaccine beyond the MVIP.
For more information, please contact:
Morayor Essieh on messieh@corporatecouncilonafrica.com.
